
Nucleosides, nucleotides and nucleic acids p. 603 - 618 (2000)
Update date:2022-08-03
Topics:
Liu, Mao-Chin
Luo, Mei-Zhen
Mozdziesz, Diane E.
Lin, Tai-Shun
Dutschman, Ginger E.
Gullen, Elizabeth A.
Cheng, Yung-Chi
Sartorelli, Alan C.
(2R,5S)-5-Amino-2-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2,4- triazine-3(2H)-one (8) and (2R,5R)-5-amino-2-[2-(hydroxymethyl)-1,3- oxathiolan-5-yl]-1,2,4-triazine-3(2H)-one (9) have been synthesized via a multi-step procedure from 6-azauridine. (2R,5S)-4-Amino-1-[2-(hydroxymethyl)- 1, 3-oxathiolan-5-yl]-1,3,5-triazine-2(1H)-one (11) and (2R,5R)-4-amino-1-[2- (hydroxymethyl)-1,3-oxathiolan-5-yl]-1,3,5-triazine-2(1H)-one (12), and the fluorosubstituted 3-deazanucleosides (19-24) have been synthesized by the transglycosylation of (2R,5S)-1-{2-[[(tert-butyldiphenylsilyl) oxy]methyl]- 1,3-oxathiolan-5-yl}cytosine (2) with silylated 5-azacytosine and the corresponding silylated fluorosubstituted 3-deazacytosines, respectively, in the presence of trimethylsilyl trifluoromethanesulfonate as the catalyst in anhydrous dichloroethane, followed by deprotection of the blocking groups. These compounds were tested in vitro for cytotoxicity against L1210, B16F10, and CCRF-CEM tumor cell lines and for antiviral activity against HIV-1 and HBV.
View MoreBeijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
SHAANXI TOP PHARM CHEMICAL CO.LTD
Contact:+86-029-85733403
Address:No.108 ,west sector,south er huan,xi'an,china
Contact:+86-532-80762375
Address:No. 6, Hongkong Middle Road, Qingdao, China
SHANXI XINTIANYUAN PHARMACEUTICAL CO., LTD.
website:http://www.tychemical.com
Contact:0086-358-3521713 3521715
Address:No. 1 Yintong Road, Shanxi Jiaocheng Economic Development Zone, Xiajiaying Town, Jiaocheng County, Lvliang City, Shanxi Province, China
Changzhou Xuanming Chemical Co., Ltd.
Contact:86 0519 85525329
Address:China Town, Xinbei, Changzhou, Jiangsu Room 6019
Doi:10.1016/S0040-4039(00)00013-7
(2000)Doi:10.1016/j.bmcl.2007.03.059
(2007)Doi:10.1055/s-0029-1218362
(2009)Doi:10.1021/ol902929a
(2010)Doi:10.1039/c7nj01892d
(2017)Doi:10.1021/acs.macromol.8b01629
(2018)